Lipid-engineered antibody-based therapeutics target inflamed joints and lymph nodes to enhance rheumatoid arthritis treatment
Cell Reports Medicine
· Elsevier
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Читать у издателя →
Цитирование
Lipid-engineered antibody-based therapeutics target inflamed joints and lymph nodes to enhance rheumatoid arthritis treatment. // Cell Reports Medicine. – URL: https://www.sciencedirect.com/science/article/pii/S2666379126005112?dgcid=rss_sd_all
Lipid-engineered antibody-based therapeutics target inflamed joints and lymph nodes to enhance rheumatoid arthritis treatment. Cell Reports Medicine. https://www.sciencedirect.com/science/article/pii/S2666379126005112?dgcid=rss_sd_all
“Lipid-engineered antibody-based therapeutics target inflamed joints and lymph nodes to enhance rheumatoid arthritis treatment.” Cell Reports Medicine.
@article{article116561,
title = {Lipid-engineered antibody-based therapeutics target inflamed joints and lymph nodes to enhance rheumatoid arthritis treatment},
journal = {Cell Reports Medicine},
url = {https://www.sciencedirect.com/science/article/pii/S2666379126005112?dgcid=rss_sd_all}
}